Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-115.49%
operating margin TTM
-115.98%
revenue TTM
170.06 Thousand
revenue per share TTM
0.03$
valuation ratios | |
|---|---|
| pe ratio | -0.53 |
| peg ratio | 0.00 |
| price to book ratio | 0.14 |
| price to sales ratio | 2.74 |
| enterprise value multiple | -2.76 |
| price fair value | 0.14 |
profitability ratios | |
|---|---|
| gross profit margin | 100.0% |
| operating profit margin | -115.98% |
| pretax profit margin | -128.05% |
| net profit margin | -115.49% |
| return on assets | -44.65% |
| return on equity | -61.39% |
| return on capital employed | -53.48% |
liquidity ratios | |
|---|---|
| current ratio | 5.06 |
| quick ratio | 5.06 |
| cash ratio | 4.47 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 90.52 |
| days of payables outstanding | 0.00 |
| cash conversion cycle | 90.52 |
| receivables turnover | 4.03 |
| payables turnover | 0.00 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.37 |
| debt equity ratio | 0.75 |
| long term debt to capitalization | 0.35 |
| total debt to capitalization | 0.43 |
| interest coverage | -11.89 |
| cash flow to debt ratio | 0.00 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.00 |
| cash per share | 33.57 |
| operating cash flow per share | 0.00 |
| free cash flow operating cash flow ratio | 0.00 |
| cash flow coverage ratios | 0.00 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time Evaxion Biotech A/S (NASDAQ:EVAX) reported earnings?
Evaxion Biotech A/S (EVAX) published its most recent earnings results on 20-08-2026.
What is Evaxion Biotech A/S's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Evaxion Biotech A/S (NASDAQ:EVAX)'s trailing twelve months ROE is -61.39%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Evaxion Biotech A/S (EVAX) currently has a ROA of -44.65%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did EVAX's net profit margin stand at?
EVAX reported a profit margin of -115.49% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is EVAX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 5.06 in the most recent quarter. The quick ratio stood at 5.06, with a Debt/Eq ratio of 0.75.